Cargando…

COVID-19 Pediatric Dermatology

Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Neale, Holly, Hawryluk, Elena B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165089/
https://www.ncbi.nlm.nih.gov/pubmed/34556241
http://dx.doi.org/10.1016/j.det.2021.05.012
_version_ 1783701239707467776
author Neale, Holly
Hawryluk, Elena B.
author_facet Neale, Holly
Hawryluk, Elena B.
author_sort Neale, Holly
collection PubMed
description Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.
format Online
Article
Text
id pubmed-8165089
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81650892021-06-01 COVID-19 Pediatric Dermatology Neale, Holly Hawryluk, Elena B. Dermatol Clin Article Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children. Elsevier Inc. 2021-10 2021-05-31 /pmc/articles/PMC8165089/ /pubmed/34556241 http://dx.doi.org/10.1016/j.det.2021.05.012 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Neale, Holly
Hawryluk, Elena B.
COVID-19 Pediatric Dermatology
title COVID-19 Pediatric Dermatology
title_full COVID-19 Pediatric Dermatology
title_fullStr COVID-19 Pediatric Dermatology
title_full_unstemmed COVID-19 Pediatric Dermatology
title_short COVID-19 Pediatric Dermatology
title_sort covid-19 pediatric dermatology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165089/
https://www.ncbi.nlm.nih.gov/pubmed/34556241
http://dx.doi.org/10.1016/j.det.2021.05.012
work_keys_str_mv AT nealeholly covid19pediatricdermatology
AT hawrylukelenab covid19pediatricdermatology